期刊文献+

聚合物纳米微球分离纯化棘白霉素B母核方法研究 被引量:3

Separation and Purification of Echinocandin B Nucleus by Polymer Nanoparticles
下载PDF
导出
摘要 以聚合物纳米微球为层析介质,采用HPLC检测方法,开发高纯度棘白霉素B母核的分离纯化工艺,并对层析条件进行优化。结果表明,当选择Uni PS 30型聚合物纳米微球为层析介质、上样量为1.2g·(100g介质)-1、以体积分数为3%的乙醇进行洗脱、流速为12mL·min-1时,得到的棘白霉素B母核纯度大于98%。建立了高纯度棘白霉素B母核的分离纯化工艺,流程简单、可行,为该产品产业化开发提供了一定的理论基础。 Using polymer nanoparticles as the chromatography medium,a method for separation and purification of high-purity echinocandin B nucleus was developed.The purity was detected by HPLC,the chromatographic conditions were optimized.Results showed that,when selecting polymer nanoparticles Uni PS 30 as the chromatography medium,loading capacity was 1.2g·(100g medium)^-1,volume fraction of ethanol was 3%,and the flow rate was 12mL·min^-1,echinocandin B nucleus with the purity of 98% were obtained.The method for separation and purification of echinocandin B nucleus was established.It was simple and feasible,which provided a theoretical basis for the industrialization of echinocandin B nucleus.
出处 《化学与生物工程》 CAS 2014年第11期31-33,共3页 Chemistry & Bioengineering
基金 国家"重大新药创制"科技专项(2014ZX09201001-002)
关键词 棘白霉素B母核 聚合物纳米微球 分离纯化 echinocandin B nucleus polymer nanoparticles separation and purification
  • 相关文献

参考文献6

二级参考文献39

  • 1仇国苏.莽草酸与禽流感治疗药——达菲[J].化学教育,2006,27(2):1-2. 被引量:17
  • 2Debono M,Gordee R S.Antibiotics that inhibit fungal cell wall development[J].Annu Rev Microbiol,1994,48(12):471-497.
  • 3Murdoch D,Ptosker G L.Anidulafungin[J].Drug,2004,64(19):2249-2 258.
  • 4Espinel-Ingroff A.Invitroantifungal activities of anidulafungin and micafungin,licensed agents and the investigational triazole pesaconazole as determined by NCCLS methods for 12 052 fungal isolates:review of the Iiterature[J].Rev Iberoam Mico,2003,20(4):121-136.
  • 5Petraitiene R,Petraitis V,Groll AH,et al.Antifungal activity of LY303366,a novel echinocandin B,in experimental disseminated candidiasis in rabbits[J].Antimicrob Agents Chemother,1999,43(9):21478-2155.
  • 6Petraitis V,Petraitiene R,Groll AH,et al.Antifungal efficacy,safety,and single-dose pharmacokinetics of LY303366,a novel echinocandin B,in experimental pulmonary aspergillosis in persistently neutropenic rabbits[J].Antimicrob Agents Chemother,1998,42(11):2898-2 905.
  • 7Vazquez J A,Sobel J D.Anidulafungin:A Novel Echinocandin[J].Clin Infect Dis,2006,42(15):215-222.
  • 8Stogniew M,Pu F,Henkel T.Antifungal biotransformatation in humans is by degradation not metabolism[C] // Program and abstracts of 13rd European congress of clinical microbiology and infectious diseases,2003:1223.
  • 9Krause D,Simjee A E,Van Rensburg C,et al.A randomized,doubleblind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis[J].Clin Infect Dis,2004,39(6):770-775.
  • 10Krause D,Reinhardt J,Vazquez JA,et al.Phaes Ⅱ.randomized dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia[J].Antimicrob Agents Chemother,2004,48(6):2 012-2 014.

共引文献34

同被引文献25

  • 1万平,冀志霞,储炬,庄英萍,张嗣良,罗家立,白骅.菌丝形态分化与头孢菌素C合成的关系[J].微生物学通报,2005,32(1):15-21. 被引量:10
  • 2陈頔,曹国颖,傅得兴,孙春华.棘白霉素类抗真菌药的研究进展[J].中国新药杂志,2007,16(14):1082-1087. 被引量:15
  • 3陈凝,王永红,储炬,巫延斌,储消和,庄英萍,张嗣良.培养基成分和补料对阿维菌素发酵过程中除虫链霉菌菌丝形态的影响[J].华中农业大学学报,2007,26(4):496-501. 被引量:12
  • 4Debono M, Turner WW, LaGrandeur L, et al. Semisynthetic chemical modification of the antifungal lipopeptide echinocandin B (ECB) : structure-activity studies of the lipophilic and geomet- ric parameters of polyarylated aeyl analogs of ECB. J Med Chem, 1995, 38(17) : 3271-3281.
  • 5Arendrup MC. Epidemiology of invasive candidiasis. Current o- pinion crtical care, 2010, 16(5) : 445-452.
  • 6Mayr A, Aigner M, Lass-Flrl C. Caspofungin : when and how? The microbiologist view. Mycoses, 2012, 55(1 ): 27-35.
  • 7Debono M, Gordee RS. Antibiotics that inhibit fungal cell wall development. Annu Rev Microbiol, 1994, 48: 471-497.
  • 8Uzun O, Kocagz S, Cetinkaya Y, et al. In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin Band fluconazole against clinical yeast isolates. Antimicrob Agents Chemother, 1997, 41(5): 1156-1157.
  • 9Joseph JM, Kim R, Reboli AC. Anidulafungin: a drug evalua- tion of a new echinocandin. Expert Opin Pharmacother, 2008, 9 ( 13 ) : 2339-2348.
  • 10Benz F, Knttsel F, Ntiesch J, et al. Metabolic products of micro- organism 143. Echinocandin B, a new polypeptide antibiotic from Aspergillus nidulans var echinulatusisolation and building units. Helv Chim Acta, 1974, 57(8) : 2459-2477.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部